These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19640198)

  • 1. Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer.
    Haghighi MM; Vahedi M; Mohebbi SR; Pourhoseingholi MA; Fatemi SR; Zali MR
    Asian Pac J Cancer Prev; 2009; 10(3):497-500. PubMed ID: 19640198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer.
    Haghighi MM; Vahedi M; Mohebbi SR; Pourhoseingholi MA; Fatemi SR; Zali MR
    Asian Pac J Cancer Prev; 2009; 10(2):209-12. PubMed ID: 19537885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer.
    Bertario L; Russo A; Sala P; Eboli M; Radice P; Presciuttini S; Andreola S; Rodriguez-Bigas MA; Pizzetti P; Spinelli P
    Int J Cancer; 1999 Jan; 80(2):183-7. PubMed ID: 9935197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of patients with Stage III colon cancer is improved in hereditary non-polyposis colorectal cancer compared with sporadic cases. A Danish registry based study.
    Brixen LM; Bernstein IT; Bülow S; Ehrnrooth E
    Colorectal Dis; 2013 Jul; 15(7):816-23. PubMed ID: 23350633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients.
    Stigliano V; Assisi D; Cosimelli M; Palmirotta R; Giannarelli D; Mottolese M; Mete LS; Mancini R; Casale V
    J Exp Clin Cancer Res; 2008 Sep; 27(1):39. PubMed ID: 18803843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients.
    You JF; Hsieh LL; Changchien CR; Chen JS; Chen JR; Chiang JM; Yeh CY; Hsieh PS; Fan CW; Liu CT; Tang R
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4244-50. PubMed ID: 16857798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival analysis in families affected by hereditary non-polyposis colorectal cancer.
    Percesepe A; Benatti P; Roncucci L; Sassatelli R; Fante R; Ganazzi D; Bellacosa A; Genuardi M; Neri G; Viel A; Ponz de Leon M
    Int J Cancer; 1997 May; 71(3):373-6. PubMed ID: 9139871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival from colorectal carcinoma in HNPCC families as compared to the general population in Lithuania--initial results.
    Elsakov P; Kurtinaitis J
    Fam Cancer; 2006; 5(4):369-71. PubMed ID: 16826317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer.
    Boks DE; Trujillo AP; Voogd AC; Morreau H; Kenter GG; Vasen HF
    Int J Cancer; 2002 Nov; 102(2):198-200. PubMed ID: 12385019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer.
    Schiemann U; Günther S; Gross M; Henke G; Müller-Koch Y; König A; Muders M; Folwaczny C; Mussack T; Holinski-Feder E
    Cancer Detect Prev; 2005; 29(4):356-60. PubMed ID: 16122885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members.
    Watson P; Lin KM; Rodriguez-Bigas MA; Smyrk T; Lemon S; Shashidharan M; Franklin B; Karr B; Thorson A; Lynch HT
    Cancer; 1998 Jul; 83(2):259-66. PubMed ID: 9669808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of recognition of the hereditary non-polyposis colon cancer syndrome (HNPCC) for the early detection of colorectal cancer.
    Jablonská M; Rezníková L; Kotrlík J; Svitavský M; Miková M; Tabach J
    Sb Lek; 1995; 96(3):275-82. PubMed ID: 8718819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of patients with ovarian cancer due to a mismatch repair defect.
    Crijnen TE; Janssen-Heijnen ML; Gelderblom H; Morreau J; Nooij MA; Kenter GG; Vasen HF
    Fam Cancer; 2005; 4(4):301-5. PubMed ID: 16341807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.
    Audenet F; Colin P; Yates DR; Ouzzane A; Pignot G; Long JA; Soulie M; Phé V; Bensadoun H; Guy L; Ruffion A; Valeri A; Cormier L; Droupy S; de La Taille A; Saint F; Faïs PO; Houlgatte A; Cussenot O; Rouprêt M;
    BJU Int; 2012 Dec; 110(11 Pt B):E583-9. PubMed ID: 22703159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-polyposis colorectal cancer in subjects under 55 years of age: frequency and phenotype of hereditary or familial syndromes].
    Di Betta E; Nascimbeni R; Ghirardi M; Alba S; Salerni B
    Ann Ital Chir; 2000; 71(2):217-24; discussion 225. PubMed ID: 10920494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register.
    Myrhøj T; Bisgaard ML; Bernstein I; Svendsen LB; Søndergaard JO; Bülow S
    Scand J Gastroenterol; 1997 Jun; 32(6):572-6. PubMed ID: 9200290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of hereditary nonpolyposis colorectal cancer (HNPCC) and the role of Japanese criteria for HNPCC.
    Fujita S; Moriya Y; Sugihara K; Akasu T; Ushio K
    Jpn J Clin Oncol; 1996 Oct; 26(5):351-5. PubMed ID: 8895676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
    Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
    Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China].
    Zhang YZ; Sheng JQ; Li SR; Wu ZT
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2995-3000. PubMed ID: 16324388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
    Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
    Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.